HYFT: MindWalk Kompaniya qiymatining sof foydaga nisbati

MindWalk Holdings, Inc. (HYFT) korporativ emblemasi va logotipi

MindWalk Holdings (HYFT) narxlar tarixi P/E koeffitsiyenti dinamikasini aks ettiradi, u hozirda -3.60 darajasida turibdi. Biznes farmatsevtika ma'lumotlari tahlilining tor segmentiga tayanadi, bu esa uni maxsus grantlarga bog'liq qiladi. AQSh bulutli markazlarining tarqatilgan tarmog'i xizmatlarning ishonchliligini ta'minlaydi. Shu bilan birga, SaaS modeli iqtisodiy pasayish davrlarida avtomatlashtirishga bo'lgan talabning o'rtacha siklliligini yumshatadi.

HYFT MindWalk Therapeutics: Narx-foyda koeffitsiyenti 05.09.2025 - 17.11.2026 oraligʻida

MindWalk Holdings, Inc. (HYFT) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:MindWalk Holdings, Inc. - HYFT
MindWalk Holdings Inc. yetakchi tovari

P/E koeffitsienti biznesning haddan tashqari qimmat yoki past baholanganligini aniqlash uchun aktivning bozor qiymatini uning bir aksiya uchun foydasi bilan solishtirish orqali investitsiyalarning qoplanish muddatini o'lchaydi. MindWalk Holdings (HYFT) kompaniyasining fundamental P/E koeffitsiyentini tahlil qilish orqali investor MindWalk Holdings raqamli barqarorligi va uning IT platformalarining logistik xatarlardan mustaqilligi kapitalning barqaror bozor qiymatiga qanday aks etishini ko'rishi mumkin.

Raqobatdosh kompaniyalar tahlili

HLN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti KVUE (Kenvue Corp)|VRNA (Verona Pharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Limited MENS|Ligand (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|Perrigo - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Technologies - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos N.V.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati anipharmaceuticals.com ANIP|Narxning foydaga nisbati MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Pacira BioSciences, Inc. PCRX|P/E multiplikatori ARS Corp SPRY|Theravance Biopharma - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - P/E multiplikatori|Narx-foyda multiplikatori SXTC (China SXT Pharmaceuticals)|P/E multiplikatori EPRX|P/E multiplikatori bioharvest.com (BHST)|Narxning foydaga nisbati Invizyne Technologies EXOZ|ORMP: Narx-foyda multiplikatori|ENTX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati ABVC BioPharma, Inc ABVC|CPIX: P/E multiplikatori|Quantum BioPharma Ltd - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti FGEN|Telomir Pharmaceuticals, Inc. - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori RANI|SNYR (Synergy CHC) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Rallybio RLYB|Lexaria Bioscience (LEXX) - Kapitalizatsiyaning foydaga nisbati|PULM - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pheton Holdings PTHL|APM (Aptorum) - Narx-foyda koeffitsiyenti|Lyra Therapeutics, Inc. (LYRA) - P/E multiplikatori|IBO (impactbiomedinc.com) - P/E multiplikatori|TNFA (TNF Pharmaceuticals) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati cbdmd.com (YCBD)|Biznesning o‘zini qoplash muddati PainReform Ltd|P/E multiplikatori CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Kapitalizatsiyaning foydaga nisbati|OPTN - Narxning foydaga nisbati|Pieris Pharmaceuticals - Bozor narxining sof foydaga nisbati|PROC (Procaps Group) - Narx-foyda koeffitsiyenti|PTPI - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Qilian International Holding Group Limited|SLRN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TFFP (TFF Pharma)